Home drug infusion therapy under Medicare

Office of Technology Assessment
Record ID 31995000190
Authors' objectives:

To evaluate the safety and effectiveness of home intravenous and other infusion drug therapy; to describe the industry providing this service; to assess options for Medicare coverage and payment for this service.

Authors' results and conclusions: Medicare does not explicitly cover home drug infusion therapy but probably pays for a substantial amount through other benefits. Explicit coverage would improve the care that patients receive but would not reduce Medicare expenditures, at least in the short run.
Authors' recommendations: OTA discusses nine issues that would arise if Medicare decided to cover this technology and presents alternative options for each (e.g. who should be eligible for the benefit, how services should be reimbursed). The report presents nine additional options relating to potentially useful research and demonstration studies.
Authors' methods: Review
Project Status: Completed
Year Published: 1992
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Drug Delivery Systems
  • Home Care Services
  • Infusion Pumps
  • Medicare
Organisation Name: U. S. Congress. Office of Technology Assessment
Copyright: Office of Technology Assessment
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.